A new subtype of artificial cell‐derived vesicles from dental pulp stem cells with the bioequivalence and higher acquisition efficiency compared to extracellular vesicles
Journal of Extracellular Vesicles · 2024
DOI: 10.1002/jev2.12473 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Extracellular Vesicles, 2024. Verfasst von Xingxiang Duan und 8 weiteren Autor:innen. Beteiligte Einrichtung: Center of Regenerative Medicine & Department of Plastic Surgery, Renmin Hospital of Wuhan University, Wuhan, China. Hauptthemen laut MEDLINE: Dental Pulp, Extracellular Vesicles, Stem Cells. Die Arbeit wurde bisher 44-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Key Research and development project of Hubei Province, key Project of Ministry of Science and Technology China, Chutian Researcher Project.
Abstract (Originalsprache)
Extracellular vesicles (EVs) derived from dental pulp stem cells (DPSC) have been shown an excellent efficacy in a variety of disease models. However, current production methods fail to meet the needs of clinical treatment. In this study, we present an innovative approach to substantially enhance the production of ‘Artificial Cell‐Derived Vesicles (ACDVs)’ by extracting and purifying the contents released by the DPSC lysate, namely intracellular vesicles. Comparative analysis was performed between ACDVs and those obtained through ultracentrifugation. The ACDVs extracted from the cell lysate meet the general standard of EVs and have similar protein secretion profile. The new ACDVs also significantly promoted wound healing, increased or decreased collagen regeneration, and reduced the production of inflammatory factors as the EVs. More importantly, the extraction efficiency is improved by 16 times compared with the EVs extracted using ultracentrifuge method. With its impressive attributes, this new subtype of ACDVs emerge as a prospective candidate for the future clinical applications in regenerative medicine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Center of Regenerative Medicine & Department of Plastic Surgery, Renmin Hospital of Wuhan University, Wuhan, China.
- Department of Stomatology, Renmin Hospital of Wuhan University, Wuhan, China.
- Institute of Regenerative and Translational Medicine, Department of Stomatology, Tianyou Hospital of Wuhan University of Science and Technology, Wuhan, Hubei, China.
- Department of Oral and Maxillofacial Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
- Department of Stomatology, Linhai Second People's Hospital, Zhejiang, China.
ORCID-Profile: Xingxiang Duan
Förderung
- Key Research and development project of Hubei Province
- key Project of Ministry of Science and Technology China
- Chutian Researcher Project
Zitieren
APA
Duan, X., Zhang, R., Feng, H., Zhou, H., Luo, Y., Xiong, W., Li, J., He, Y., & Ye, Q. (2024). A new subtype of artificial cell‐derived vesicles from dental pulp stem cells with the bioequivalence and higher acquisition efficiency compared to extracellular vesicles. Journal of Extracellular Vesicles. https://doi.org/10.1002/jev2.12473
Vancouver
Duan X, Zhang R, Feng H, Zhou H, Luo Y, Xiong W, et al. A new subtype of artificial cell‐derived vesicles from dental pulp stem cells with the bioequivalence and higher acquisition efficiency compared to extracellular vesicles. Journal of Extracellular Vesicles. 2024. doi:10.1002/jev2.12473
BibTeX
@article{Duan2024,
author = {Duan, Xingxiang and Zhang, Rui and Feng, Huixian and Zhou, Heng and Luo, Yu and Xiong, Wei and Li, Junyi and He, Yan and Ye, Qingsong},
title = {A new subtype of artificial cell‐derived vesicles from dental pulp stem cells with the bioequivalence and higher acquisition efficiency compared to extracellular vesicles},
journal = {Journal of Extracellular Vesicles},
year = {2024},
doi = {10.1002/jev2.12473}
}
EUVIMED